@article {Ibanez:October 2006:0300-7995:1893, author = "Ibanez, Y.", author = "Rodriguez, J.M.", author = "Lujan, M.", author = "Grattan, T.J.", author = "Martin, A.J.", author = "Burnett, I.", title = "A pharmacokinetic study investigating the rate of absorption of a 500 mg dose of a rapidly absorbed paracetamol tablet and a standard paracetamol tablet", journal = "Current Medical Research and Opinion", volume = "22", year = "October 2006", abstract = "Objective: A rapidly absorbed tablet formulation of paracetamol containing sodium bicarbonate (PS) has been previously shown to be absorbed at least twice as fast as a standard paracetamol tablet (P) at a 1 g dose. In South America and Asia it is customary for patients to take a 500 mg dose of analgesic. The objective of this pharmacokinetic study was to compare the rate of absorption of PS versus P at a 500 mg dose.

Research design and methods: An open, randomized, single dose, cross-over study. Thirty Hispanic healthy volunteers randomly received a 500 mg dose taken orally with 50 mL of water 2 h after a standard breakfast. Blood samples were taken up to 10 h post-dose. Plasma concentrations of paracetamol were determined by HPLC with UV detection.

Main outcome measures: AUC0-30 min, Cplasma 30 min and Tmax were analyzed non-parametrically by the Wilcoxon's rank sum test. A linear mixed effects model was used to analyze the logarithmically transformed AUC0-∝ and Cmax. Bioequivalence was accepted if the 90% confidence intervals (CI) for the ratio of the means of the primary pharmacokinetic variable AUC0-∝ lay completely within the range 0.80-1.25.

Results: AUC0-30 min and Cplasma 30 min were significantly greater and Tmax was significantly shorter (all p < 0.0001) for PS versus P. The formulations were bioequivalent for AUC0-∝ (90% CI 0.99:1.05) and no statistical difference was seen for Cmax (95% CI 0.91:1.14).

Conclusions: Paracetamol was absorbed at least twice as fast from PS compared to P at a 500 mg dose. The extent of absorption was equivalent for both formulations.", pages = "1893-1897(5)", url = "http://www.ingentaconnect.com/content/apl/cmro/2006/00000022/00000010/art00003" doi = "doi:10.1185/030079906X132596" }